EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC-ND 4.0

Beyond RAS G12 grouping: testing treatment-specific prediction after daraxonrasib in pancreatic cancer

Jian Zheng, Luyang Chi, Yong Guo

Cancer Treatment and Research Communications · 2026 · 49 · 101503

DOI: 10.1016/j.ctarc.2026.101503 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Jian Zheng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Zhejiang Provincial Hospital of Chinese Medicine, The First Affiliated Hospital of Zhejiang University of Chinese Medicine, H…. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Circulating tumor DNADaraxonrasibKRAS mutationMolecular evolutionPancreatic ductal adenocarcinomaPrecision oncologyRAS inhibition

Autor:innen und Institutionen

  • Department of Oncology, Zhejiang Provincial Hospital of Chinese Medicine, The First Affiliated Hospital of Zhejiang University of Chinese Medicine, Hangzhou, 310000, Zhejiang, China.
  • Department of Oncology, Zhejiang Provincial Hospital of Chinese Medicine, Hangzhou, Zhejiang, 310000, China. Electronic address: guoyong1047@zcmu.edu.cn.

Zitieren

APA

Zheng, J., Chi, L., & Guo, Y. (2026). Beyond RAS G12 grouping: testing treatment-specific prediction after daraxonrasib in pancreatic cancer. Cancer Treatment and Research Communications, 49, 101503. https://doi.org/10.1016/j.ctarc.2026.101503

Vancouver

Zheng J, Chi L, Guo Y. Beyond RAS G12 grouping: testing treatment-specific prediction after daraxonrasib in pancreatic cancer. Cancer Treatment and Research Communications. 2026;49:101503. doi:10.1016/j.ctarc.2026.101503

BibTeX
@article{Zheng2026,
  author = {Zheng, Jian and Chi, Luyang and Guo, Yong},
  title = {Beyond RAS G12 grouping: testing treatment-specific prediction after daraxonrasib in pancreatic cancer},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  volume = {49},
  pages = {101503},
  doi = {10.1016/j.ctarc.2026.101503}
}
Kostenlos starten →